 SOUTH SAN FRANCISCO, Calif., June 25, 2021 GLOBE NEWSWIRE -- VistaGen Therapeutics, Inc . NASDAQ: VTGN, a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system CNS disorders, today announced that it will host a corporate update conference call on Tuesday, June 29, 2021 at 2:00 pm Pacific Time 5:00 pm Eastern Time to discuss its financial and operating results for its fiscal year ended March 31, 2021 and provide a business update. 